New Drug with Immunotherapy Has Potential to Treat Kidney (and) Lung Cancer

New investigational drug Pegilodecakin with immunotherapeutic drug pembrolizumab and nivolumab shown to be safe in Phase 1B study.

from Medindia Health News https://ift.tt/2lXBXGU